STEROL SYNTHESIS, SYNTHESIS OF 25,26,26,26,27,27,27-HEPTAFLUOROCHOLEST-5-EN-7-ONE AND ITS EFFECTS ON HMG-COA REDUCTASE-ACTIVITY IN CHINESE-HAMSTER OVARY CELLS, ON ACAT ACTIVITY IN RAT JEJUNAL MICROSOMES, AND SERUM-CHOLESTEROL LEVELS IN RATS
Jn. Carroll et al., STEROL SYNTHESIS, SYNTHESIS OF 25,26,26,26,27,27,27-HEPTAFLUOROCHOLEST-5-EN-7-ONE AND ITS EFFECTS ON HMG-COA REDUCTASE-ACTIVITY IN CHINESE-HAMSTER OVARY CELLS, ON ACAT ACTIVITY IN RAT JEJUNAL MICROSOMES, AND SERUM-CHOLESTEROL LEVELS IN RATS, Chemistry and physics of lipids, 94(2), 1998, pp. 209-225
3 beta-Hydroxycholest-5-en-7-one (I; 7-ketocholesterol) is an oxystero
l of continuing interest in biology and medicine. In the present study
, we have prepared a side-chain fluorinated analog, 3 beta-hydroxy-25,
26,26,26;27,27,27-heptafluoro- cholest-5-en-7-one (VI), with the antic
ipation that the F-7 substitution would block major metabolism of the
7-ketosterol, and thereby enhance its potential in vivo effects on ser
um cholesterol levels and other parameters. Chromium trioxide/dimethyl
pyrazole oxidation of the acetate derivative of the previously descri
bed 25,26,26,26,27,27,27-heptafluorocholest-5-en-3 beta-ol (Swaminatha
n et al., 1993. J. Lipid Res. 34, 1805-1823) followed by mild alkaline
hydro lysis gave VI. The effects of VI on 3-hydroxy-3-methylglutaryl
coenzyme A (HMG-CoA) reductase activity in Chinese hamster ovary (CHO-
K1) cells, on acyl coenzyme A-cholesterol acyltransferase (ACAT) activ
ity in rat jejunal microsomes, and on serum cholesterol levels and oth
er parameters in male Sprague-Dawley rats were determined and compared
with those obtained with I and with another alpha,beta-unsaturated ke
tosterol, i.e. 3 beta-hydroxy-5 alpha-cholest-8(14)-en-15-one (II). I
and VI showed essentially the same potency, considerably less than tha
t of II? in lowering the levels of HMG-CoA reductase activity in CHO-K
1 cells. Whereas addition of LT to rat jejunal microsomes inhibited AC
AT activity (IC50 similar to 3 mu M), I and VI had no effect under the
conditions studied (from 1 to 16 mu M). Dietary administration of I,
at levels of 0.1 and 0.15%, had no effect on food consumption, gain in
body weight, or serum cholesterol levels. At 0.2%. I caused a modest
decrease in body weight gain and a slight decrease in serum cholestero
l levels (relative to ad libitum but not pair-fed control animals). Th
e F-7-7-ketosterol VII at 0.26'% in diet (the molar equivalent of 0.2%
I), had no effect on food consumption, body weight, or serum choleste
rol levels. Administration of I (0.1. 0.15 or 0.2% in diet) caused inc
reases in the weight of small intestine. In contrast? no effect of VI
(0.26% in diet) on small intestinal weight was observed. (C) 1998 Else
vier Science ireland Ltd. All rights reserved.